US Stock MarketDetailed Quotes
CRSP CRISPR Therapeutics
- 50.590
- -0.170-0.33%
Close Nov 4 16:00 ET
- 50.040
- -0.550-1.09%
Post 16:47 ET
4.31BMarket Cap-15809P/E (TTM)
51.900High49.215Low1.60MVolume50.440Open50.760Pre Close81.50MTurnover1.91%Turnover RatioLossP/E (Static)85.17MShares91.10052wk High2.18P/B4.24BFloat Cap43.42052wk Low--Dividend TTM83.72MShs Float220.200Historical High--Div YieldTTM5.29%Amplitude11.630Historical Low50.989Avg Price1Lot Size
CRISPR Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Nov 4, 2024
The average CRISPR Therapeutics stock price target is 68.75 with a max estimate of 105.00 and a min estimate of 30.00
Review CRISPR Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Nov 4, 2024
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
